NovoCure Ltd

NVCR

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001822014-26-000003
Filing date: Mar 5, 2026
Earliest execution date: Mar 4, 2026
Reporting Owners: Cordova Ashley (CEO)
SEC Filing link

Summary

Type

Sell

Net shares

-17,638

% of shares

-4.01%

Amount (USD)

$234,585

Insider confidence score

42.5 out of 100

Positive

  • Tax withholding obligation

Negative

  • Large tax withholding sell (≥1% of shares)
  • Significant sell amount ($50K+)

Stock transactions

Transaction 1

Security

Ordinary Shares

Action

Tax_withhold

Date

2026-03-04

Code

F

Net shares

-17,638.0

Price per Share

$13.30

Amount (USD)

$234,585.40

Acquired/Disposed

Disposed

Shares Owned Before

440,208.0

Shares Owned After

422,570.0

Filing's footnotes

1. Represents the number of shares required to be withheld by the issuer to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This transaction is not discretionary and approved as required pursuant to Rules 16b-3(e) and 16b-3(d)(1).

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.